Liver transplantation is the preferred treatment for end-stage liver diseases, with a 90% 1-year and 70% 5-year survival rate. It is recommended for patients with hepatocellular carcinoma, acute liver failure, or certain metabolic disorders. Advancements in surgical methods, new immunosuppressive drugs, and the adoption of living donor liver transplants have enhanced overall clinical outcomes. Patient selection criteria are shaped by various factors and will continue to evolve alongside efforts to expand the donor pool, refine surgical techniques, broaden transplant indications, and prolong graft longevity.
To enhance your understanding of the indication, evaluation, and outcomes of liver transplant surgeries, we bring you a special session on this World Liver Day by proficient HPB and Transplant Surgeon Dr. Mahesh Gopasetty on 19 th April 2024, 6:00 PM IST onwards. Stay Tuned!…
